Effect of Therapeutic and Supratherapeutic Oral Doses of GSK3640254 on Cardiac Conduction Compared to Placebo and a Single Oral Dose of Moxifloxacin
Clinical trial NCT04563845 · COMPLETED
Trial details
- NCT number
- NCT04563845
- Sponsor
- ViiV Healthcare
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-09
- Primary completion
- 2021-10-30
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.